A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer

NCT02742051 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Everolimus
DRUG: Letrozole
DRUG: Fluorouracil
DRUG: Epirubicin
DRUG: Cyclophosphamide

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University